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and synthetic culture media with several carbon sources 
of different origins (11,12). Nevertheless, BC membranes 
maintain a physical barrier that reduces pain, bacterial 
infection and allows drug transfer into the wounded region 
(13–15). These BC membranes characteristics constitute 
an important aim to development of studies for application 
this biopolymer as drug delivery system (16–18).  
The aim of the present mini-review was to show the 
wide and vantages application of the BC and its copolymers 
for use as controlled drug delivery system.
Application of bacterial cellulose as a drug 
delivery system
In recent years, several drug delivery systems based in 
BC membranes for various pharmaceutical applications 
have been proposed including antimicrobial, and anticancer 
agents,  small molecules, inorganic nanoparticles and a 
metal complex (19).
Studies developed by Stoica-Guzun et al. (20) 
demonstrated the delivery of the antibiotic tetracycline 
encapsulated on BC matrix comparing irradiated (doses of 
5 or 15 kGy) to non-irradiated BC membranes an in 
vitro study demonstrating that electron beam radiated over 
BC-tetracycline system promoted faster drug release rate.
Introduction
Polymeric drug delivery systems may be designed 
in many forms, including matrices, composites, pure 
membranes and copolymers in which the bioactive 
compound must be dispersed or dissolved (1,2). The route 
of administration, carrier formulation, release mechanism 
and physicochemical properties of the drug molecule 
may influence the rate of release and, therefore, should 
be considered when selecting a suitable polymer for this 
purpose (2,3).  In addition, the polymers used for the 
development of drug delivery systems must be chemically 
inert and present appropriate physical and chemical 
characteristics (2). In the last years, BC (Figure 1), a 
very interesting biopolymer, has been widely applied in 
transdermal drug delivery as membranes, being commonly 
used in the fabrication of matrix-type patches due singular 
properties (4), such as high degree purity and of porosity, 
relative high permeability to liquid and gases, high holding 
water capacity, tensile strength and randomly oriented 
three-dimension fibers network, viscoelasticity and 
poroelasticity (5,6).  
BC can be produced by several organisms species, 
(7,8) with special emphasis to cellulose produced by 
bacteria of the genus Gluconacetobacter, recently named 
Komagataeibacter (Figure 2), especially the species K. 
xylinus and K. hansenii (6,9,10),  using a variety of natural 
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Antimicrobial bacterial cellulose-silver nanoparticles 
composite membranes obtained by in situ preparation of 
silver nanoparticles from hydrolytic decomposition of 
silver nitrate solution using triethanolamine as reducing 
and complexing agent exhibited strong antimicrobial 
activity against Gram-positive S. aureus and Gram-
negative E. coli and P. aeruginosa bacteria Gram-positive 
S. aureus (21). 
In another work, Kaplan et al. (22) performed a 
comparative study to evaluate the in vitro release behavior 
of gentamicin (GM) and ampicillin (AMP) by BC 
membranes. These authors demonstrated that membranes 
exhibited sustained release capacity of AMP and GM in 7 
days and the amounts of antibiotic released by BC reached 
the proportion of dose required to inhibit the growth of E. 
coli, E. feacalis, S. aureus and P. aeruginosa.
In study using the Box-Behnken statistical design 
to study the release of amoxicillin (AMX) from the BC, 
BC / glycerol and BC / hexadecyltrimethylammonium 
bromide enhancer showed that amoxicillin concentration 
had a greater influence on drug release and a significant 
contribution was also observed for the linear and 
quadratic terms of the glycerol concentration, the linear 
concentration of potentiator, and the interaction between 
the concentration of glycerol and concentration of the 
enhancer. These results show that independent variables 
affevct the release of AMX from BC membranes (23). 
In vitro antibacterial assay using BC composite 
membranes prepared with tetracycline hydrochloride 
(BC-TCH) demonstrates that this composites displayed 
excellent antibacterial activity solely associated with the 
loaded TCH drug (24).
A study using immobilized lysozyme onto BC 
nanofibers (BCNF) produced by physical absorption 
method was performed to evaluate the antimicrobial 
activity and other properties of immobilized lysozyme 
and also morphological characteristics of BCNF.  This 
result  demonstrates that the antimicrobial activity of 
lysozyme against S. aureus, E. coli, L. monocytogenes, 
Y. entrocolitica, Aspergillus niger, and Saccharomyces 
cerevisiae were increased after immobilization evidencing 
the  potential  for  the  use  of  BCNF as lysozyme delivery 
system (25).
Transparent antimicrobial silver nanoparticles/bacterial 
cellulose (AgNPs/BC) membranes produced by reducing 
silver nitrate as a precursor in the presence of sodium 
tripolyphosphate and in situ impregnation into the BC 
membranes. The AgNPs/BC membranes were nontoxic 
and showed good biocompatibility on peripheral blood 
mononuclear cells due to the controlled silver ion release. 
According to the results, it is suggested that the AgNPs/
BC membranes can be applied for many antimicrobial 
purposes such as antibacterial wound dressing (26).
In a study, using bilayer BC membrane produced by 
G. hansenii  ATCC 23769, from sugar-cane molasses 
carbon sources, impregnated with ceftriaxone (CRO), was 
demonstrated a higher capacity for retention and release of 
CRO when compared to the commercial BC membranes (18). 
In a recent study, Volova et al. (27) demonstrated 
Figure 1 – Swollen BC membrane and Scanning Electron Microscopy (SEM) BC membranes randomly oriented three-dimension 
fibers network (50.000x).. 
Figure 2 - Scanning Electron Microscopy (SEM) G. hansenii 
ATCC 23769 (37.000x)
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pronounced antibacterial activity against E. coli, P. 
aeruginosa, K. pneumoniae, and S. aureus, and the BC/
antibiotics amikacin and ceftriaxone composites were more 
active than BC/AgNp. S. aureus was the most susceptible 
to the effect of BC composites. 
Lazarini et al. (18), obtained a dissimilar BC membrane 
with high drug delivery capacity by G. hansenii variety 
achieve  after application  of  different  culture  temperatures. 
The BC membrane produced by variety acquired from 
the culture at 35º C produced membranes with dissimilar 
degrees of interweaving and fibers thickness and high dry 
mass yield.  This BC obtained was impregnated with CRO 
and maintained release capacity for 72 hours.
A new hybrid material based on bacterial cellulose 
containing silver phosphate microparticles on one side 
of the matrix and high ciprofloxacin loading has been 
developed by Bayón et al. (28).  The AgP-MPs developed 
by the self-assembly technique on only one side of the 
bacterial cellulose surface provide a novel and promising 
composite material with excellent antimicrobial activity 
against both Gram-positive S. aureus and Gram-negative 
E. coli bacteria. The BC membranes obtained showed 
relevant properties such as non-adhesive hydrogel dressing 
capability, high skin tissue compatibility, excellent 
water uptake ability, high mechanical strength, and air 
permeability.
In a study designed to prepare surface modified BC 
matrices by treatment with acetic anhydride, freeze drying, 
and oven drying, the BC was loaded with model drugs 
selected based on their aqueous solubility, faintly water-
soluble famotidine and highly water-soluble tizanidine. 
The chemical structure, the concentration of the drug 
loaded, the concentration of the surface modifier and the 
modifications pre and post-loading of the drug altered the 
physicochemical properties of the BC matrices, which 
in turn affected the drug release behavior. The obtained 
results demonstrated that the surface modifications were 
found  to  be  effective  for  controlling  the  drug  release 
properties  demonstrating the  potential  these BC matrices 
for  applications  as  modified  drug  delivery system (29).
Results obtained in recent study, development by Lima 
Fontes (30), BC/ carboxymethylcelullose (BC/CMC) 
biocomposites with different DS-CMC (DS from 0.7 to 
1.2) were loaded with methotrexate (MTX), drug used 
treatment of psoriasis, an autoimmune disorder of skin, in 
order to evaluate their impact as a drug delivery system. 
All samples showed a typical burst release effect in the 
first 15 min of a test, however, the BC/CMC (DS0.9) 
biocomposite promoted a slight lowering of MTX release 
rates, suggesting that the DS of CMC can be considered 
the key factor to modulate the BC properties.
A novel hybrid biomaterial composed bacterial 
cellulose hydrogel and nanostructured lipid carriers 
(NLCs) for application as local drug delivery implant for 
cancer therapy using doxorubicin (Dox) as drug model 
were described by Cacicedo et al. (31). NLCs loaded 
with cationic Dox (NLCs-H) or neutral Dox (NLCs-N) 
were fully characterized and their cell internalization and 
cytotoxic efficacy were evaluated in vitro against MDA-
MB-231 cells. Both NLCs internalized via the endocytic 
pathway while allowing a sustained release of the Dox, 
which in turn rendered IC50 values below of those of free 
Dox. Thereafter, a combination of NLCs-H and NLCs-N 
loaded into BC (BC-NLCs-NH) was analyzed in vivo into 
an orthotopic mouse model. BC-NLCs-NH showing a 
significant reduction in tumor growth, metastasis incidence 
and local drug toxicities. These results demonstrate the 
potential use of BC-NLCs-NH as local drug delivery 
system.
Conclusion
After reviewing published data, it was evident that 
BC membrane and copolymers showed high potential 
pharmaceutical use with advantage application for the 
controlled drug delivery system justifying the increase 
of the interest of the researchers in the development of 
products based in BC to this application.
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